GlobeNewsWire
29 Sept 2026, 21:39 UTC · 2h ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
Verdict
Headline takes no side. We score BEAM −0.80 across two claims — strongly bearish.
- Expected · BEAM
−0.80strongly bearish
−1 bearish0bullish +1More negative than 84% of ticker scores this week





